Related Experiment Video
Updated: Apr 15, 2026

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Integrating emerging treatment options in mantle cell lymphoma: introduction
1UW Carbone Cancer Center Madison, WI.
Abstract:
Mantle cell lymphoma (MCL) is a unique subtype of non-Hodgkin lymphoma (NHL). MCL accounts for approximately 6% of new lymphoma cases each year.1 Because it is a relatively uncommon form of lymphoma, it is more difficult to study than other lymphoma subtypes. There are many single-arm, phase 2 trials in the MCL literature, but there is a relative paucity of large, randomized, phase 3 trials. As a result, comparisons are often made across trials, and observations are based on extrapolation.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)